Accredited Investors Inc. Celcuity Inc. Transaction History
Accredited Investors Inc.
- $1.5 Billion
- Q1 2024
A detailed history of Accredited Investors Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Accredited Investors Inc. holds 29,115 shares of CELC stock, worth $490,005. This represents 0.04% of its overall portfolio holdings.
Number of Shares
29,115
Previous 29,115
-0.0%
Holding current value
$490,005
Previous $424,000
48.11%
% of portfolio
0.04%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding CELC
# of Institutions
82Shares Held
22.9MCall Options Held
24.9KPut Options Held
4K-
Perceptive Advisors LLC New York, NY2.36MShares$39.8 Million1.07% of portfolio
-
Morgan Stanley New York, NY2.35MShares$39.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.73MShares$29.1 Million3.06% of portfolio
-
Commodore Capital LP New York, NY1.56MShares$26.2 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY1.55MShares$26.1 Million0.42% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $251M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...